In total, 90% of cases of HHT are due to a pathogenic mutation in the ENG or ACVRL1 genes, although pathogenic variants related to HHT have also been described in other genes such as MADH4, GDF2, or RASA-1. This evidence concerns the gene SMAD4 and hereditary hemorrhagic telangiectasia.